|
|
Title: Allergy inhibition
United States Patent: 7,112,334
Issued: September 26, 2006
Inventors: Freiberg;
Roberta C. (Maple Glen, PA)
Appl. No.: 10/106,288
Filed: March 26, 2002
|
|
|
Pharm/Biotech Jobs
|
Abstract
Allergen contact with a person's
allergen-responsive tissues is reduced by removing airborne allergens from
body surfaces adjacent the person's eyes. Airborne allergens may be
removed from body surfaces adjacent the person's eyes by irrigating such
areas with an irrigating fluid or by wiping such areas with a pad.
Preferably the irrigating fluid or the pad is treated to augment its
effectiveness in removing airborne allergens or otherwise preventing them
from entering the eye, and/or to reduce allergy symptoms in the eye area
caused by airborne allergens that enter the eye.
Description of the Invention
BACKGROUND OF THE
INVENTION
1. Field of the Invention
This invention relates to methods and apparatus for inhibiting the
occurrence of and/or reducing the extent of allergic responses to airborne
allergens. More particularly, this invention relates to methods and
apparatus for reducing allergen contact with a person's
allergen-responsive tissues.
2. Description of Related Art
A significant number of people suffer from allergies. According to some
estimates, tens of millions of Americans suffer from allergies to airborne
particles such as pollen, animal dander, dust, or mold. One method that
people have used to address their allergy problems is oral ingestion of
antihistamines. While oral antihistamines can be effective in mitigating
allergy symptoms, their use entails exposing the entire body to a
pharmaceutical product, and they may produce unpleasant or harmful side
effects. Another method that people have used to address their allergy
problems is to control their environment in an attempt to reduce their
exposure to airborne allergens. For instance, they may try to stay in
air-conditioned buildings as much as possible when the air contains a
large amount of pollen, or they may try to avoid places where cats or
other animals are or have been. This method may be quite inconvenient, and
may be of limited effectiveness because it is difficult to avoid at least
some contact with airborne allergens.
SUMMARY OF THE
INVENTION
In accordance with the present invention,
allergen contact with a person's allergen-responsive tissues is reduced by
removing airborne allergens from body surfaces adjacent the person's eyes.
Airborne allergens may be removed from body surfaces adjacent the person's
eyes by irrigating such areas with an irrigating fluid or by wiping such
areas with a pad. Preferably the irrigating fluid or the pad is treated to
augment its effectiveness in removing airborne allergens or otherwise
preventing them from entering the eye, and/or to reduce allergy symptoms
in the eye area caused by airborne allergens that enter the eye.
DETAILED DESCRIPTION
OF THE INVENTION
Airborne allergens such as pollen, animal
dander, dust, and mold typically do not trigger allergic responses when
they contact external body surfaces. However, airborne allergens may enter
the body via the nose, the mouth, or the eyes and contact
allergen-responsive tissues, which may result in an allergic response. As
used herein, the term "airborne allergens" means particulate allergens
that are typically carried by the air, such as pollen, animal dander,
dust, and mold, regardless of whether the particles at any particular time
are airborne or reside on some surface; thus "airborne allergens" includes
particulate allergens that have been deposited on the skin or other
surface of a person after having been airborne. Many allergy symptoms
involve the eyes, and the eyes can be an important location of allergen
contact with allergen-responsive tissues. Some airborne allergens land
directly on the tear film covering the cornea or conjunctiva, where they
become entrained in the tear film and may be conveyed into contact with
allergen-responsive tissues that the tears contact. Other airborne
allergens arrive at the cornea or conjunctiva indirectly; they may first
land on adjacent body surfaces such as the eyelashes, eyelids, or
eyebrows, and may later become dislodged and contact the cornea or
conjunctiva. The latter route to the eye can be significant.
In accordance with the present invention, allergen contact with a person's
allergen-responsive tissues is reduced by removing airborne allergens from
body surfaces adjacent the eyes. By removing airborne allergens from body
surfaces adjacent the eyes, the airborne allergens cannot later become
dislodged from such surfaces, enter the eyes, and contact
allergen-responsive tissues. Removal of airborne allergens from the
eyelids may also effect removal of allergens that have been entrained in
the tear film and swept from the cornea or conjunctiva by blinking.
Airborne allergen removal from body surfaces adjacent the eyes may be
effected in a variety of ways. Such areas may be irrigated with a fluid.
Water or an aqueous solution may be used for this purpose. With an
appropriate irrigation fluid, the eye may be irrigated at the same time as
are the body surfaces adjacent the eyes. The irrigation fluid may contain
components to provide the fluid with particular characteristics or to
enhance particular characteristics of the fluid. For instance, substances
such as detergents may be included in the irrigation fluid to enhance its
ability to remove airborne allergens from the body surfaces adjacent the
eyes. Antihistamines may be included in the irrigation fluid to provide
topical antihistamine administration to the eyes and/or body surfaces
adjacent the eyes. Substances may be included in the irrigation fluid that
leave a residue on the body surfaces adjacent the eyes tending to entrain
or immobilize airborne allergens that land on such surfaces. Substances
may be included in the irrigation fluid that diminish the allergenic
effect of airborne allergens that land on such surfaces.
Another way of removing airborne allergens from body surfaces adjacent the
eyes is to wipe such surfaces with a pad. Such a pad may be made from
paper or cloth, and may be treated so as increase its effectiveness at
removing airborne allergens or otherwise inhibit airborne allergens from
entering the eye, to reduce the allergenic effect of airborne allergens
that land on body surfaces adjacent the eyes, to otherwise alleviate
allergy symptoms, or to otherwise improve its characteristics in use. A
pad may be treated to render it electrostatically attractive so as to
attract and retain airborne allergens; this may be primarily effective for
airborne allergens located in the eyelashes and eyebrows, and less
effective for airborne allergens located on the eyelids where they may
tend to adhere in oils on the skin or in tears or tear residues. A pad may
be treated with a fluid to moisten it and enhance its ability to remove
airborne allergens from the body surfaces adjacent the eyes. Water or an
aqueous solution may be used for this purpose. The pad moistening fluid
may contain components to provide the fluid with particular
characteristics or to enhance particular characteristics of the fluid. For
instance, substances such as detergents may be included in the pad
moistening fluid to enhance its ability to remove airborne allergens from
the body surfaces adjacent the eyes. Antihistamines may be included in the
pad moistening fluid to provide topical antihistamine administration to
the eyes and/or body surfaces adjacent the eyes. Substances may be
included in the pad moistening fluid that leave a residue on the body
surfaces adjacent the eyes tending to entrain or immobilize airborne
allergens that land on such surfaces. Substances may be included in the
pad moistening fluid that diminish the allergenic effect of airborne
allergens that land on such surfaces. Skin-treating substances such as
moisturizers may be added to the pad moistening fluid. Pads in accordance
with this invention may be individually packaged for convenience in
carrying them.
In accordance with the present invention, airborne allergens may be
removed from body surfaces adjacent the eyes in a variety of
circumstances. Airborne allergens may be removed from body surfaces
adjacent the eyes in response to a determination that the person has been
exposed to airborne allergens sufficiently to warrant their removal from
body surfaces adjacent the eyes. For instance, this determination may be
made upon a person experiencing allergy symptoms, or upon determining the
amount of airborne allergen that has settled on or about the person, or
upon observation that the person has been in an environment where a large
exposure to airborne allergens may occur, such as a cat-owner's home or a
meadow. Airborne allergens may be removed from body surfaces adjacent a
person's eyes in predetermined circumstances, such as periodically or at
certain times of day or in connection with predetermined events, such as
upon returning home or after travel.
Although particular features and embodiments of the invention have been
described herein, variations may no doubt be made by those skilled in the
art without departing from the spirit and scope of the invention.
Claim 1 of 17 Claims
1. A method of reducing
allergen contact with a person's allergen-responsive tissues comprising the
steps of: (a) determining that removal of airborne allergens from the person
is warranted; and (b) removing airborne allergens from external areas of the
person's body adjacent the person's eyes.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|